Search

everythinglearnresearchcommunity

for

Search:↓

The compounds tested could potentially treat hair loss and alopecia.

Androgenetic alopecia can be treated with minoxidil and finasteride, requiring long-term use and patient cooperation.

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Eriocitrin and silymarin might be effective for hair loss treatment and need more research.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Androgen treatment with dihydrotestosterone may help maintain height in patients with 5-α-reductase type 2 deficiency, especially before puberty.

Combining micro-needling, LED therapy, and growth factors with Finasteride® significantly improves hair growth.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

5 alpha-reductase inhibitors like finasteride may lower prostate cancer risk and improve cancer screening.

Taking tadalafil and finasteride together is safe and effective for treating urinary symptoms and erectile dysfunction in men with enlarged prostates.

Finasteride helps reduce prostate size and symptoms in BPH but is less effective than terazosin and works best for larger prostates.

Both surgical and non-surgical hair loss treatments lack a standard treatment plan and sufficient patient satisfaction data.

Post-finasteride syndrome causes lasting sexual, mental, and physical issues, needing more research for solutions.

Camellia seed cake extract may help hair growth by blocking the hair loss effects of a hormone called DHT.

The article concludes that treating hair loss requires careful research, understanding the causes, and personalized treatment plans.

The growth factor cocktail significantly increased hair growth in patients with androgenetic alopecia.

Tributyltin exposure causes sex changes, sterilization, and decline in the snail Ocinebrina aciculata, risking its extinction.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

The conclusion suggests that PCOS may persist due to genetic traits that, while harmful for female fertility, could have provided survival and reproductive benefits to males.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

A male with aromatase deficiency improved bone health with estradiol treatment.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

Finasteride and dutasteride are effective in treating male hair loss but can cause sexual side effects and birth defects.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.